Dr. Gao has more than 20 years of experience in biotechnology and pharmaceutical industry, with a focus on cancer biology, cellular assay development, biomarker discovery and patient stratification. He has led oncology programs from target development to Phase I trials at many companies, including Incyte Corporation and Novartis Institutes for Biomedical Research. He received his…
Mr. Chu has 20 years of experience in the healthcare industry and broad experience in business and corporate development, including investments, licensing, and M&A. Prior to joining CBC Group, he was Senior Director of Corporate and Business Development at Spectrum Pharmaceuticals, leading business development efforts for the company. Before Spectrum Pharmaceuticals, he worked on Wall Street…
Dr. Borgman is a highly accomplished CMO, business executive, scientific advisor, and board director with over 20 years of experience in clinical development and oncology-hematology drug approvals. She has led teams to successful approvals of several oncology assets, including recombinant asparaginase and cabozantinib. Dr. Borgman has a broad network and depth of regulatory interactions, enabling…
Dr. Yao is CEO and Chairman of ArriVent Biopharma and has over 25 years of experience in the biotechnology and pharmaceuticals industry. He co-founded Viela Bio in 2018, serving as Chairman and CEO, which was acquired by Horizon Therapeutics for $3 billion in 2021. Prior to Viela, he held leadership positions at MedImmune and AstraZeneca,…
Chris has 10+ years of biotech investment and industry combined experience. He received a PhD in Biochemistry from SUNY Stony Brook and a BS in Chemistry from Fudan University. He also received his MBA in Finance and Management from NYU Stern School of Business.
Dr. Jia is the Founder of Octagon Capital and has served as the firm’s Chief Investment Officer since 2019. Prior to founding Octagon Capital, Dr. Jia served as Managing Director at Hillhouse Capital Management. Before Hillhouse Capital Management, Dr. Jia was an investment analyst at BVF Partners and a management consultant at McKinsey’s New York…
Mr. Fu is the CEO of CBC Group and has over 18 years of private equity experience. He oversees the firm’s strategy, investments, talent development, and maintains partnerships with global investors. He led several of the firm’s investments and was instrumental in incubating biotech and pharmaceutical companies. Before founding CBC Group in 2014, he managed…
